CA2517517C — P38 inhibitors and methods of use thereof
Assigned to Array Biopharma Inc · Expires 2012-12-18 · 13y expired
What this patent protects
This invention relates to inhibitors of p38, and methods for producing these inhibitors. The compounds having the general formula (see above formula) The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the in…
USPTO Abstract
This invention relates to inhibitors of p38, and methods for producing these inhibitors. The compounds having the general formula (see above formula) The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders mediated by p38.
Drugs covered by this patent
- Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.